Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
64.34
-2.77 (-4.13%)
Jun 25, 2026, 4:00 PM EDT - Market closed
Tarsus Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 3, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $100 | Buy | Reiterates | $100 | +55.42% | May 27, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $88 | Buy | Maintains | $88 | +36.77% | May 26, 2026 |
| Barclays | Barclays | Buy Maintains $100 | Buy | Maintains | $100 | +55.42% | May 15, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $95 | Buy | Reiterates | $95 | +47.65% | May 9, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $90 | Buy | Reiterates | $90 | +39.88% | May 8, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 7, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $105 → $98 | Buy | Maintains | $105 → $98 | +52.32% | Apr 24, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.